CHE Share Price Performance
US$540.57
117.24 (27.69%)
8.1% overvalued intrinsic discount
US$500.00
Fair Value
Price US$540.57
AnalystHighTarget US$500.00
AnalystConsensusTarget US$501.50
Fair ValueUS$500.00
Share Pricen/a
Narrative Update • Jul 29
Chemed Corporation Stock Price
- 2 Narratives written by author
- 0 Comments on narratives written by author
- 12 Fair Values set on narratives written by author
CHE Community Narratives
AN
Fair Value
·Fair Value US$500 8.1% overvalued intrinsic discount
Repositioned Hospice Mix And Aging Demographics Will Support Stronger Long Term Performance
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value
·Fair Value US$501.5 7.8% overvalued intrinsic discount
New Florida CON Sites Will Advance Home-Based And Hospice Care
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
New Florida CON Sites Will Advance Home-Based And Hospice Care
Chemed’s hospice business is expanding into underserved parts of Florida just as more families choose care at home, which could lift patient volumes over time. But its results also depend heavily on government payments and a plumbing services unit facing softer demand and rising costs.Read more
AN
US$501.5
7.8% overvalued intrinsic discount
Fair Value
Revenue
6.3% p.a.
Profit Margin
12.76%
Future PE
15.49x
Price in 2029
US$581.53
Repositioned Hospice Mix And Aging Demographics Will Support Stronger Long Term Performance
Chemed’s hospice business is changing who it brings in, aiming for steadier patients that could make results more predictable over time. Add in an aging population and a push to grow both hospice and its home-services unit, and the upside story comes down to whether those shifts stick—or run into tougher competition and changing rules.Read more
AN
US$500
8.1% overvalued intrinsic discount
Fair Value
Revenue
6.86% p.a.
Profit Margin
13.47%
Future PE
14.72x
Price in 2029
US$577.8
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
CHE: Buybacks And Activist Pressure Will Shape Margins And Measured Returns
Fair Value: US$501.5 7.8% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
CHE: Strong Q1 Results And Buybacks Support Balanced Future Return Potential
Fair Value: US$500 8.1% overvalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Chemed Corporation Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
- 21.13
- 33.11%
- 10.60%
- 16.9%
About CHE
- Founded
- 1970
- Employees
- 15811
- CEO
- WebsiteView website
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
